NCT05878704View on ClinicalTrials.gov

Study of GBT021601 in Participants With Renal Impairment

PHASE1TerminatedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

June 29, 2023

Primary Completion Date

July 29, 2024

Study Completion Date

July 29, 2024

Conditions

Renal Impairment

Interventions

DRUG

GBT021601

Oral

Trial Locations (4)

33147

Advanced Pharma CR, LLC, Miami

55114

Nucleus Network, Saint Paul

92630

Orange County Research Center, Lake Forest

92780

Orange County Research Center, Tustin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT05878704 - Study of GBT021601 in Participants With Renal Impairment | Biotech Hunter | Biotech Hunter